1. Patient-reported outcomes in patients with resected, high-risk melanoma with BRAFV600E or BRAFV600K mutations treated with adjuvant dabrafenib plus trametinib (COMBI-AD): a randomised, placebo-controlled, phase 3 trial. Issue 5 (May 2019) Authors: Schadendorf, Dirk; Hauschild, Axel; Santinami, Mario; Atkinson, Victoria; Mandalà, Mario; Chiarion-Sileni, Vanna; Larkin, James; Nyakas, Marta; Dutriaux, Caroline; Haydon, Andrew; Robert, Caroline; Mortier, Laurent; Lesimple, Thierry; Plummer, Ruth; Schachter, Jacob; Dasgupta, Kohinoor; Manson, S... Journal: Lancet oncology Issue: Volume 20:Issue 5(2019) Page Start: 701 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Chronic cardiovascular toxicity in the older oncology patient population. Issue 5 (September 2019) Authors: Findlay, Simon G.; Gill, Jason H.; Plummer, Ruth; DeSantis, Carol; Plummer, Chris Journal: Journal of geriatric oncology Issue: Volume 10:Issue 5(2019) Page Start: 685 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Pembrolizumab as a Cause of Cholangiopathy in a Patient With Metastatic Melanoma. Issue 6 (30th May 2020) Authors: Stuart, Laura; Lambourne, Beth; Turner, Paul; Jones, David E.J.; Plummer, Ruth; Cresti, Nicola; Dyson, Jessica K. Journal: Hepatology Issue: Volume 71:Issue 6(2020) Page Start: 2164 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. BRAF Wild-type, PTEN Mutant Malignant Uveal Melanoma Arising Within a Mature Ovarian Teratoma: A Case Report and Review of the Literature. (July 2020) Authors: Lengyel, Krisztina; Young, Fergus; Kucukmetin, Ali; Cresti, Nicola; Plummer, Ruth; Ralte, Angela; O'Donnell, Rachel Louise Journal: International journal of gynecological pathology Issue: Volume 39:Number 4(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Tisotumab vedotin in patients with advanced or metastatic solid tumours (InnovaTV 201): a first-in-human, multicentre, phase 1–2 trial. Issue 3 (March 2019) Authors: de Bono, Johann S; Concin, Nicole; Hong, David S; Thistlethwaite, Fiona C; Machiels, Jean-Pascal; Arkenau, Hendrik-Tobias; Plummer, Ruth; Jones, Robert Hugh; Nielsen, Dorte; Windfeld, Kristian; Ghatta, Srinivas; Slomovitz, Brian M; Spicer, James F; Yachnin, Jeffrey; Ang, Joo Ern; Mau-Sørensen, Pa... Journal: Lancet oncology Issue: Volume 20:Issue 3(2019) Page Start: 383 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Safety, pharmacokinetic, pharmacodynamic and clinical activity of molibresib for the treatment of nuclear protein of the testis carcinoma and other cancers: Results of a Phase I/II open‐label, dose escalation study. Issue 6 (26th November 2021) Authors: Cousin, Sophie; Blay, Jean‐Yves; Garcia, Irene Braña; de Bono, Johann S.; Le Tourneau, Christophe; Moreno, Victor; Trigo, Jose; Hann, Christine L.; Azad, Arun A.; Im, Seock‐Ah; Cassier, Philippe A.; French, Christopher A.; Italiano, Antoine; Keedy, Vicki L.; Plummer, Ruth; Sablin, Marie‐Paule; He... Journal: International journal of cancer Issue: Volume 150:Issue 6(2022) Page Start: 993 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Managing adverse events associated with vismodegib in the treatment of basal cell carcinoma. (January 2017) Authors: Fife, Kate; Herd, Robert; Lalondrelle, Susan; Plummer, Ruth; Strong, Amy; Jones, Sarah; Lear, John T Journal: Future oncology Issue: Volume 13:Number 2(2017) Page Start: 175 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. A phase 1b study evaluating the safety and preliminary efficacy of berzosertib in combination with gemcitabine in patients with advanced non-small cell lung cancer. (January 2022) Authors: Plummer, Ruth; Dean, Emma; Arkenau, Hendrik-Tobias; Redfern, Charles; Spira, Alexander I.; Melear, Jason M.; Chung, Ki Y.; Ferrer-Playan, Jordi; Goddemeier, Thomas; Locatelli, Giuseppe; Dong, Jennifer; Fleuranceau-Morel, Patricia; Diaz-Padilla, Ivan; Shapiro, Geoffrey I. Journal: Lung cancer Issue: Volume 163(2022) Page Start: 19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Safety and efficacy of nivolumab in challenging subgroups with advanced melanoma who progressed on or after ipilimumab treatment: A single-arm, open-label, phase II study (CheckMate 172). (November 2019) Authors: Schadendorf, Dirk; Ascierto, Paolo A.; Haanen, John; Espinosa, Enrique; Demidov, Lev; Garbe, Claus; Guida, Michele; Lorigan, Paul; Chiarion-Sileni, Vanna; Gogas, Helen; Maio, Michele; Fierro, Maria Teresa; Hoeller, Christoph; Terheyden, Patrick; Gutzmer, Ralf; Guren, Tormod K.; Bafaloukos, Dimitr... Journal: European journal of cancer Issue: Volume 121(2019) Page Start: 144 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanoma. Issue 7 (6th July 2022) Authors: Bhave, Prachi; Ahmed, Tasnia; Lo, Serigne N; Shoushtari, Alexander; Zaremba, Anne; Versluis, Judith M; Mangana, Joanna; Weichenthal, Michael; Si, Lu; Lesimple, Thierry; Robert, Caroline; Trojanello, Claudia; Wicky, Alexandre; Heywood, Richard; Tran, Lena; Batty, Kathleen; Dimitriou, Florentia; St... Journal: Journal for immunotherapy of cancer Issue: Volume 10:Issue 7(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗